SCi olive

Empresa de ingeniería con más de 20 años de experiencia asesorando a empresas en gestión agronómica y desarrollo de proyectos de I+D


Av. San Fco. Javier 24, planta 8 mod. 11
+34 954659324
Av. San Fco. Javier 24. Planta 8 / Módulo 11
Monday to Friday - 08:00 a 15:00h.
Closed saturdays

R&D Projects / SCI Olive


The NEOCANTAL project aims to obtain dietary supplements very rich in a specific phenolic compound called Oleocantal from olives.

Work is underway to offer the NEOCANTAL product in three different formats:

Powder – Oleocantal richness up to 30,000 mg/kg (use: food additive)
Liquid – Oleocantal richness up to 50,000 mg/kg (use: food additive and cosmetic industry)
Encapsulated – Oleocantal richness up to 80,000 mg/kg (use: nutraceutical supplement, providing maximum Oleocantal bioavailability).


Clinical trials carried out by various scientists have highlighted the anti-inflammatory and antioxidant properties of the oleocanthal molecule. This exceptional compound is synthesized mainly in the few olive tree cultivars identified by SCI. Thus, oleocantal is present in both olives and extra virgin olive oil (EVOO), although in lower concentrations.

Scientist Beauchamp, along with his collaborators, identified the anti-inflammatory effect of oleocantal and its similarities to ibuprofen, noting that this compound could combat various diseases related to chronic inflammation, such as arthritis, rheumatoid arthritis, and Alzheimer’s, among others. The scientist recommends daily and continuous long-term consumption of 50 g of EVOO with a minimum oleocantal concentration of 200 mg/kg (equivalent to 9 mg/day/person). However, it is important to note that this dose corresponds to only 10% of the recommended ibuprofen dose for pain relief in an adult.

Ingesting more than 50 g of EVOO per day would be impossible because it would harm a person’s balanced diet. The World Health Organization and Dietary Intake References suggest that you should only obtain between 20% and 35% of total calories from fat sources.

Furthermore, in 2011, the European Food Safety Authority considered that daily consumption of 5 mg of phenols from EVOO, contributes to the antioxidant protection of lipids in the blood. Numerous clinical trials have demonstrated the positive effects against degenerative diseases (Alzheimer’s), cardiovascular diseases, and cancerous diseases, among others (Lopez-Huertas & Fonolla, 2017; Parkinson & Cicerale, 2016; Qosa et al., 2015; Rallo et al., 2018).

As we mentioned previously, achieving the recommended daily dose of oleocanthal would require ingesting a total of 0.5 kg of EVOO per person per day (with a concentration of 200 mg/kg), which would be practically impossible.

“NEOCANTAL” will be the only product that will allow the recommended daily dose of oleocanthal to be achieved without affecting

“NEOCANTAL” can be taken directly in pills or introduced into different food matrices.


SCI Olive is currently in the process of applying for the Neocantal project within the EIC ACCELERATOR program. In the evaluation of the first phase, we have received an extremely positive assessment, securing approval from all evaluators in every aspect. At this moment, we await the resolution of the second phase, which will provide us with the opportunity to go to Brussels and defend the project in the last step to ensure the necessary funding.

The Neocantal project aims to highlight the value of the SCI OLIVE patent, enabling us to obtain Oleocantal in high concentration and stable form from the olive tree. Oleocantal, a polyphenol with extraordinary characteristics, is distinguished by its anti-inflammatory effect, often compared to ibuprofen but without the associated negative effects, in addition to its antioxidant properties. These qualities make it a suitable option for individuals with inflammatory diseases who cannot consume ibuprofen.